Products Antibodies Phosphorylated Antibodies Phospho-PLN-T17 Rabbit pAb - P26678
Phospho-PLN-T17 Rabbit pAb - P26678

Phosphorylated Antibodies

Phospho-PLN-T17 Rabbit pAb - P26678

Item Number : CM0001871

Price varies based on specs and customizations


Application
WB, IHC-P, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
6kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name Phospho-PLN-T17 Rabbit pAb
Remarks/Alias PLB; CMD1P; CMH18; Phospho-PLN-T17
Species Human
GeneID (human) 5350
GeneID 5350
Immunogen Synthetic peptide: A synthetic phosphorylated peptide around T17 of human PLN (NP_002658.1)
Source Rabbit
Category Phosphorylated Antibodies
Application WB, IHC-P, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS P26678
Protein Weight 6kDa
Shipping Ice bag

Biological Background: Phospholamban Function and Localization

  • Phospholamban (PLN), also known as PLB, is a 52-amino acid transmembrane phosphoprotein predominantly expressed in cardiac muscle.
  • It reversibly inhibits the sarcoplasmic reticulum Ca2+-ATPase SERCA2 (ATP2A2) by reducing its apparent affinity for Ca2+, thereby slowing Ca2+ re-uptake during muscle relaxation (PubMed:28890335). Related references: PMID:28890335
  • PLN also modulates cardiac contractility in response to β-adrenergic stimulation; phosphorylation at Thr17 by CaMKII relieves SERCA2 inhibition, enhancing Ca2+ transport.
  • Subcellularly, PLN localizes to the endoplasmic/sarcoplasmic reticulum membrane and also to the mitochondrial membrane, where it may influence calcium signaling and energy metabolism.
  • PLN activity is regulated by its oligomeric state and post-translational modifications, including phosphorylation, acetylation, and palmitoylation, which affect its inhibitory function.
  • Mutations in PLN are linked to dilated cardiomyopathy (CMD1P) and hypertrophic cardiomyopathy (CMH18), highlighting its critical role in cardiac function.

Experimental Guidance and Technical Tips

  • The immunogen is a synthetic phosphorylated peptide around Thr17; this antibody is expected to detect phospholamban only when phosphorylated at this site. Avoid using this antibody for detecting total PLN.
  • For Western blot (WB), note the predicted molecular weight is 6 kDa; consider using a high-percentage gel (e.g., 12–15% Tris-tricine) and careful transfer conditions for small proteins.
  • For immunohistochemistry (IHC-P), validate in cardiac muscle tissue where PLN is highly expressed; consider antigen retrieval methods appropriate for phospho-specific antibodies.
  • For ELISA, the peptide-based immunogen suggests the antibody may work well in peptide competition assays; validate in the relevant sample system.
  • Cross-reactivity is reported for human, mouse, and rat; for other species, check sequence homology around the phosphorylation site.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio supplies this high-quality anti-phospho-PLN (Thr17) antibody alongside complementary IVD raw materials, including matched antibody pairs, recombinant proteins, and ancillary reagents for cardiac biomarker research. With end-to-end support from concept to clinic, we help diagnostic developers accelerate assay development for cardiac and phosphorylated protein targets. Contact our team for bulk orders or customized sourcing solutions.

View more faqs for this product

Product Datasheet

Phospho-PLN-T17 Rabbit pAb - P26678


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!